Organon & Co | OGN - 应收帐款人

股票价格
13.36
每天变化
0.02 0.15%
每月一次
45.06%
每年
51.73%
Q2 预测
13.07




应收帐款人 更改 日
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Celltrion KRW 2.05T 542.39B 2025-12
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 52K 4.95M 2025-12
Divis Laboratories Ltd INR 26.28B 1.16B 2025-09
Gilead Sciences USD 4.74B 172M 2026-03
Glaxosmithkline GBP 10.45B 707.81M 2025-12
Kangmei Pharma CNY 3.15B 295.48M 2025-09
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Merck USD 11.78B 345M 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Organigram Holdings CAD 49.94M 14.92M 2025-12
Organon & Co USD 1.33B 153M 2025-12
Ovoca Bio EUR 39K 408K 2025-06
Pharma Mar EUR 51.19M 9.4M 2026-03
Qiagen NV USD 402.61M 9.05M 2025-12
Sartorius EUR 366.6M 74.9M 2026-03
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Tilray USD 109.07M 2M 2025-09
Zealand Pharma A/S 340M 94.1M 2025-12